The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity

Yukinari Kato(Tohoku University), Mika K. Kaneko(Tohoku University), Akiko Kunita(Bunkyo University), Satoshi Ogasawara(Kyoto University), Yuki Fujii(Hokkaido University of Science), Shinji Abe(Tokushima University), Masashi Fukayama(The University of Tokyo), Hiroharu Oki(Yamagata University), Yasuhiko Nishioka(Tokushima University)
Oncotarget
September 25, 2015
Cited by 62


Related Papers